DV
Dividend Vision

TEVA — Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited (TEVA)

Its deepest 1-year drawdown was 21.8%.

Teva Pharmaceutical Industries Limited develops, manufactures, and distributes generic medicines, specialty pharmaceuticals, and biopharmaceutical products globally, with a focus on central nervous system, respiratory, and oncology treatments. The company does not currently distribute to shareholders. Teva operates as a traditional operating company with no expense ratio, appealing primarily to investors seeking equity exposure to the pharmaceutical sector rather than income-focused portfolios.

TEVA key facts

Asset type
Stock
Asset class
Equity
Inception date
02/16/1982
Distribution frequency
Quarterly
5-year average yield
2.95
Last close
$36.77
Market cap
$42,847,940,608
Average volume
2332500.0
Ex-dividend date
11/27/2017
Payment date
12/12/2017
Beta
0.875
Payout ratio
0.0
P/E ratio
61.2833
Forward P/E
17.4216
EPS
$0.60